Cairo – Mubasher: The ordinary general meeting (OGM) of October Pharma has approved to increase cash dividends for fiscal year 2016 to EGP 3.5 from proposed dividends of EGP 3.
The OGM also adopted the financial statements for the year ended on 31 December 2016, in addition to the board and auditor’s reports on the year, according to a bourse filing.
